Skip to main content
Signal8

Kim Jean Jinsun

SEC insider (Form 3/4/5 filer). CIK 0001839917. Director at Avidity Biosciences, Inc. (RNAM). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 27, 2026. Located in SAN DIEGO, CA.

Companies Kim Jean Jinsun has filed insider reports for

  • Avidity Biosciences, Inc. (RNAM): Director
Kim Jean Jinsun profile photo

Kim Jean Jinsun

CIK: 0001839917

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Avidity Biosciences, Inc. logo
RNAM

Avidity Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Avidity Biosciences, Inc. logo
    RNAM

    Avidity Biosciences, Inc.

    Feb 27, 2026
    Disposition
    Direct
    6.7K shares-
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Jun 10, 2025
    Award
    Direct
    6.7K shares-

1-2 of 2